• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Strides Pharma Science Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16996.0
  • ISIN : INE939A01011
836.55 -38 (-4.30%)
  • As on 03 Aug 2025 (EOD)

  • Today’s Low

    816.65

  • Today’s High

    875.50

  • Open

    873.00

  • Perv Close

    874.10

  • 52W Low

    449.40

  • 52W High

    972.00

Key Indicators

  • P/E(TTM)

    125.10

  • Mar.Cap (₹Cr.)

    7,710.71

  • Div & Yield %

    0.48

  • Book Value(₹)

    346.39

  • Debt-Equity Ratio

    -4.30

  • AGM Date

    01-Aug-2025

  • EPS

    6.69

  • P/E Ratio

    125.10

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    7,710.71

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    92.17

  • BV (₹)

    346.40

  • Sales( ₹ in Cr.)

    2,139.42

  • NP (in Cr.)

    2,886.34

  • NP Var(%)

    5663.0

  • Div%

    40.0

  • CPS (₹)

    322.30

  • EPS (₹)

    313.10

  • Traded Value (₹ in Lakhs)

    7,714.40

  • 52 Week High

    972.00

  • 52 Week Low

    449.40

  • Price BSE

    837.0

  • Price NSE

    837.00

  • Market Capital( in Cr.)

    7,714.40

  • P/C Ratio

    2.60

  • P/E Ratio

    2.70

  • Price Vs.BV

    313.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93
Other Income 2,873.24 127.54 84.07 123.49 117.09 93.07
Stock Adjustments 27.20 -14.87 -21.04 -114.26 117.53 2.88
Total Income 5,039.86 1,978.79 1,917.53 1,988.23 2,092.19 1,787.88
EXPENDITURE :            
Raw Materials 1,110.74 954.29 1,044.57 987.26 1,106.41 894.84
Power and Fuel Cost 36.00 47.90 45.54 43.76 45.82 44.53
Employee Cost 377.59 348.92 267.01 272.09 272.72 230.23
Other Manufacturing Expenses 132.85 143.04 130.03 151.87 134.86 117.43
Selling and Administration Expenses 246.18 192.14 182.64 260.83 171.51 117.95
Miscellaneous Expenses 0.85 19.83 80.19 72.31 84.56 85.37
Employee Benefit Expenses 377.59 348.92 267.01 272.09 272.72 230.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,904.21 1,706.11 1,749.98 1,788.12 1,815.87 1,490.35
Operating Profit 3,135.66 272.68 167.54 200.11 276.32 297.53
Interest 145.91 139.38 138.68 74.24 65.34 66.84
Gross Profit 2,989.75 133.30 28.86 125.87 210.98 230.69
Depreciation 84.61 87.41 93.62 104.37 99.34 94.24
Profit Before Tax 2,905.14 45.89 -64.76 21.50 111.64 136.45
Current Tax -1.46 -0.12 -49.84 -169.66 33.65 18.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 20.39 1.46 -19.60 10.98 -0.26 -2.59
Reported Net Profit 2,886.21 44.55 4.68 180.19 78.24 120.28
Extraordinary Items -0.12 -5.53 -16.32 4.23 3.26 3.41
Adjusted Net Profit 2,886.33 50.08 21.00 175.96 74.98 116.87
Adjustment below Net Profit -2,827.06 -57.19 0.00 0.00 0.00 -57.25
P & L Balance brought forward 719.38 745.57 740.89 583.13 522.80 616.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 22.99 13.55 0.00 22.43 17.91 156.30
P & L Balance carried down 755.55 719.38 745.57 740.89 583.13 522.80
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 25.00 15.00 0.00 25.00 140.00
Dividend Per Share(Rs) 4.00 2.50 1.50 0.00 2.50 14.00
Earnings Per Share-Unit Curr 313.16 4.85 0.52 20.07 8.72 13.43
Earnings Per Share(Adj)-Unit Curr 313.16 2.13 0.23 8.79 3.82 5.88
Book Value 346.42 383.84 380.71 379.36 362.18 352.68
Book Value(Adj)-Unit Curr 346.42 168.20 166.83 166.24 158.71 154.54

Shareholding Pattern

  • Promoter Group

    28.30%

  • Public Share Holding

    71.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 241,594 0.26 241,594 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,108,899 4.46 4,108,899 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 300,000 0.33 300,000 1
Others 0 0.00 0 0
Sub Total 26,078,579 28.30 26,078,579 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,125 0.01 8,125 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,025 0.01 7,999 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 25,822,887 28.02 25,822,887 251
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,636,581 2.86 2,636,581 4
Mutual Funds / UTI 8,133,229 8.82 8,133,229 12
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,483,110 1.61 1,483,110 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,092,957 41.33 38,091,931 287
2] Non Institution
Bodies Corporate 3,566,224 3.87 3,565,106 712
Clearing Members 689 0.00 689 1
Directors of their Relatives 61,243 0.07 61,243 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,008,048 2.18 2,006,721 1,259
Foreign Non Institution Other 21,000 0.02 21,000 1
Hindu Undivided Families 1,306,596 1.42 1,306,596 1,948
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,738,103 8.40 7,738,103 105
Individuals holding nominal share capital up to Rs. 1 lakh 12,634,105 13.71 12,570,837 87,422
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,358 0.01 5,358 7
Others 649,812 0.71 649,812 1,126
Sub Total 27,991,178 30.37 27,925,465 92,586
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,162,714 100.00 92,095,975 92,889

Company Background

Strides Pharma Science LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Strides Pharma Science Ltd
  • BSE Code : 16996.0
  • ISIN : INE939A01011

  • Incorporation Year

    1990

  • Registered Office

    No 201 Devavrata Sector 17
    Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924/27893199

  • FAX

    91-22-27892942

  • Chairman

    Arun Kumar

  • Managing Director

    Arun Kumar

  • Company Secretary

    Manjula Ramamurthy

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Strides Pharma Science Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Strides Pharma 836.95 2,185.61 2,139.42 125.10 4.62
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10